Shanghai Allist Pharmaceuticals Co., Ltd. (SHA:688578)

China · Delayed Price · Currency is CNY

111.20

-4.36 (-3.77%)

Jul 31, 2026, 3:00 PM CST

SHA:688578 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	5,673	5,187	3,558	2,018	791	530.09
Revenue Growth	44.95%	45.80%	76.29%	155.14%	49.22%	94409.97%
Gross Profit	5,463	5,023	3,414	1,940	743.9	500.14
Operating Income	2,571	2,297	1,475	548.3	38.64	-69.81
Net Income	2,415	2,189	1,430	644.17	130.52	18.27
Earnings Per Share	5.36	4.86	3.18	1.43	0.29	0.04
EPS Growth	57.19%	52.83%	122.38%	393.10%	625.00%	-

Revenue by Geography

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
China	5,152
Overseas	35
Total	5,187

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	3,159	3,546	3,626	2,512	2,037	2,260
Total Debt	4.41	3.89	1.3	1.82	1.96	5.39
Net Cash (Debt)	3,154	3,542	3,625	2,510	2,035	2,255
Net Cash Growth	-13.45%	-2.30%	44.42%	23.32%	-9.73%	-12.99%
Net Cash Per Share	7.00	7.86	8.06	5.57	4.52	4.94

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	2,484	2,323	1,566	674.65	91.63	29.29
Capital Expenditures	-136.55	-186	-270.22	-67.88	-143.83	-192.25
Free Cash Flow	2,347	2,137	1,296	606.77	-52.21	-162.95
Free Cash Flow Growth	78.85%	64.88%	113.56%	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	96.31%	96.83%	95.97%	96.14%	94.05%	94.35%
Operating Margin	45.32%	44.28%	41.45%	27.17%	4.88%	-13.17%
Pretax Margin	49.55%	49.06%	45.49%	32.52%	15.93%	3.45%
Profit Margin	42.57%	42.20%	40.19%	31.92%	16.50%	3.45%
FCF Margin	41.38%	41.19%	36.42%	30.06%	-6.60%	-30.74%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Aug '26 Aug 1, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Dividend Per Share	1.200	1.000	0.650	0.400
Dividend Per Share Growth	53.85%	53.85%	62.50%	-
Dividend Yield	1.08%	0.97%	1.10%	0.99%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 1, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	20.74	21.41	18.85	29.10	67.85	743.66
Forward PE	18.16	22.45	17.64	28.70	74.26	109.82
P/FCF Ratio	21.32	21.94	20.80	30.90	-	-
PS Ratio	8.82	9.04	7.58	9.29	11.20	25.64